Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Huakang Biomedical Holdings Co Ltd
8622Current price
0.19 HKD
0 HKD (0.00%)
Last closed
0.19 HKD
Company
www.huakangbiomedical.com
ISIN
KYG4644W1069
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Hong Kong Stock Exchange
Capitalization
98 488 955 HKD
Yield for 12 month
+24.18 %
1Y
3Y
5Y
10Y
15Y
8622
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China, Hong Kong, and Canada. The company provides male fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; and auxiliary reproductive supplies and equipment. It also offers healthcare products and supplements under the Nutronic brand through its websites, including nutronic.ca and nutronic.hk; offline channels, such as Eugenebaby and green price shops; and e-commerce platforms comprising Tmall, JD.com, Amazon, HKTVmall, Eugenebaby, etc. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong. Address: Kimberley House, Tsim Sha Tsui, Hong Kong
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+26 961 788 HKD
Last Year
+27 729 184 HKD
Current Quarter
+7 504 285 HKD
Last Quarter
+6 906 570 HKD
Current Year
+17 617 284 HKD
Last Year
+18 516 047 HKD
Current Quarter
+4 840 837 HKD
Last Quarter
+4 517 898 HKD
Key Figures 8622
1 year
3 years
5 years
10 years
EBITDA
-5 211 497 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-6.37 %
PEG Ratio
–
Return On Equity TTM
-10.98 %
Wall Street Target Price
–
Revenue TTM
25 055 535 HKD
Book Value
0.11 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
4.5 %
Dividend Yield
–
Gross Profit TTM
16 438 636 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
-41.4 %
Profit Margin
-24.34 %
Dividend Analytics 8622
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 8622
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 8622
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.2011
Price Sales TTM
3.9308
Enterprise Value EBITDA
-26.9017
Price Book MRQ
1.5442
Financials 8622
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 8622
For 52 weeks
0.08 HKD
0.21 HKD
50 Day MA
0.14 HKD
Shares Short Prior Month
–
200 Day MA
0.12 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart